What changed
$RVTY — WATCHLIST 📊
Revvity, Inc. provides health sciences solutions, technologies, and services.
🎯 Q2 2026 | Rev $1B | EPS $1.06 vs $1.01 🟢
💡 Consensus may have underestimated the magnitude of the beat, but the market reaction has been muted, suggesting the beat was within the range of expectations. Our variant view is that the current valuation and poor quantitative rankings imply limited upside, and the expectations gap is narrow or negative.
📉 Reward/Risk: 0.0:1
🏢 Business Quality: 6/10 - The company appears to have stable operations with a recent earnings beat, but the high PE and low model rank suggest it may be overvalued relative to fundamentals or facing headwinds.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/RVTY0622
Also in play: $TMO $DHR $WAT $PKI $A $NVDA
Why it matters
Revvity, Inc. provides health sciences solutions, technologies, and services.